Open original FDA record ↗Recall record
- FDA identifier
- Z-1373-2013
- Company in FDA record
- Nephron Pharmaceuticals Corp.
- FDA classification date
- May 29, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.
Source facts
- Action
- The firm, Nephron Pharmaceuticals Corporation, notified its consignees on April 30, 2013, and May 3, 2013, of the problem via a recall notice and a Press Release, respectively. The firm directed consignees to discontinue use of any EZ Breathe atomizer units contained in the Asthmanefrin Starter Kits with the affected lot numbers and also those that were sold individually. Customers were directed to return all affected product.
- Initiated
- 2013-04-30
- Root cause
- Nonconforming Material/Component
- Terminated
- 2016-06-28
- Distribution
- Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.
- Recall number
- Z-1373-2013
- Recall status
- Terminated
- CDRH record ID
- 117836
- FDA classified
- 2013-05-29
- Recall event number
- 65070